People · Operator
Named in public records as an officer, director or promoter · active 2022–2026 · Biotechnology, Other, Biotech, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Atomwise Inc. | — | Biotechnology | Series D+ | $238.6M | $124.4M | 2024 |
| Notable Labs, Inc. | — | Biotechnology | Series B | $82.2M | $132.1M | 2022 |
| Positive Development, Inc. | — | Other | Series B | $72.2M | $119.8M | 2022 |
| Synapticure, Inc. | — | Biotech | Series C | $40.1M | $332.9M | 2024 |
| Sift Medical Data, Inc. | — | Healthtech | Series B | $30.7M | $143.6M | 2024 |
Adam Seabrook at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Adam Seabrook on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Phillips | 1 | 14 |
| Matt Ocko | 1 | 13 |
| Eric Anderson | 1 | 11 |
| James Kim | 1 | 10 |
| Andrew Walker | 1 | 7 |
| Brenton Fargnoli | 1 | 7 |
| John Banta | 1 | 6 |
| Robert Mittendorff | 1 | 5 |
| Mark Pacala | 1 | 5 |
| Kenneth Cunningham | 1 | 4 |
| Roy Beveridge | 1 | 4 |
| Michael Horowitz | 1 | 4 |
| Kiersten Stead | 1 | 4 |
| Raj Ganguly | 1 | 4 |
| Joseph Wagner | 1 | 3 |
| Gavin Teo | 1 | 3 |
| Kurt Brenkus | 1 | 2 |
| Daniel Gebremedhin | 1 | 2 |
| Marc Kiven | 1 | 2 |
| Linda Maxwell | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.